Cardinal Health, Boston scientific corporation, and Medtronic are Dominating the U.S. Emergency Medical Transportation Market in 2021

U.S. Emergency Medical Transportation Market is expected to grow with a CAGR of 7.4% %in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-emergency-medical-transportation-market

U.S. emergency medical transportation markets a highly consolidated market, which includes a specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favorable market scenarios.

The major players dealing in the U.S. emergency medical transportation market are introducing a strong range of product portfolios. This helped companies to maximize sales with an enhanced product portfolio.

For instance,

  • In January 2020, ConvaTec Group Plc released ConvaMax, the NEW superabsorber dressing distributed by ConvaTec. ConvaMax superabsorber wound dressing is used to manage highly exuding wounds, including leg ulcers, pressure ulcers, diabetic foot ulcers, and dehisced surgical wounds. This launch has helped the company to increase its customer reach.
  • In July 2020, Koninklijke Philips N.V. launched a pre-hospital wireless monitoring solution for emergency medical response in the U.S. This launch has helped patients in emergency cases which will ultimately increase the goodwill of the company.

U.S. Emergency Medical Transportation Market Cardinal Health

Cardinal Health is headquartered in Ohio, U.S. It was founded in 1971.  The company focuses on providing a safer and healthier world by providing high-quality medical equipment. The company-wide range of product categories such as pharmaceutical and medical, of which the market-focused category is medical.

  • In July 2019, Cardinal Health had acquired the Patient Recovery Business of Medtronic located in plc Mansfield and specialized in M.A. patient care, deep vein thrombosis, and nutritional insufficiency. This acquisition will help the company increase the customer base and ultimately help in the growth of the revenue.

The company has a presence in Europe, North America, Latin America, and Asia- Pacific.

Boston scientific corporation

Boston scientific corporation is headquartered in Massachusetts, U.S. It was founded in 1979. The company focuses on contributing to a safer and healthier world by providing customers with innovative and high-quality medical equipment. The company offers various product categories such as medical specialties, gastroenterology, electrophysiology, of which the market-focused category is medical specialties.

  • In May 2021, Boston Scientific Corporation announced the completion CE Mark for the EXALT Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures in the intensive care unit, operating room, and bronchoscopy suite. This development is beneficial for the company in terms of marking its products in bronchoscope categories and single-use device technology.

The company has a presence in Europe, North America, Latin America, the Middle East and Africa, and Asia- Pacific.

Medtronic

Medtronic is headquartered in Dublin, Ireland, founded in 1949. The company focuses on the treatment of various health conditions and provides the best solutions for the patients. The company offers various product categories such as cardiac and vascular, minimally invasive therapies, patient monitoring, and diabetes, of which the market-focused category is patient monitoring systems.

  • In May 2019, Medtronic announced the U.S. commercial launch of the SonarMe airway monitoring system; the SonarMed airway monitoring system utilizes acoustic technology to check for endotracheal tube (ETT) obstruction and verifies position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their smallest patients. This product launch is beneficial to the company in terms of product expansion in the monitoring systems portfolio, especially in the endotracheal tube segment.

The company has a presence in Europe, Asia Pacific, Africa, Middle East, North America, and South America.